Bristol-Myers Squibb was granted a patent for BTK-inhibiting compounds.

{
  "signal_id": "15cdaaef-6290-59cf-98ee-319b3de00fd4",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-10-14T15:26:40+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C07D 401/10"
      },
      {
        "code": "A61P 29/00"
      },
      {
        "code": "A61P 37/00"
      },
      {
        "code": "C07D 209/08"
      },
      {
        "code": "C07D 209/18"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In October 2026 Bristol-Myers Squibb patented drug candidates for treating autoimmune and vascular diseases through targeted pharmaceutical therapies.",
    "summary": "Bristol-Myers Squibb was granted a patent for BTK-inhibiting compounds.",
    "event_at": "2026-10-13",
    "inventors": [
      {
        "name": "Qingjie Liu",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Scott Hunter Watterson",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "John E. Macor",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/john-e-macor-7557b211"
      },
      {
        "name": "Khehyong Ngu",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/khehyong-ngu-7b223810"
      },
      {
        "name": "Saleem Ahmad",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-10-13",
    "source_url": "https://patents.google.com/patent/US12759999",
    "cpc_primary": {
      "code": "C07D 401/10"
    },
    "patent_title": "Indole carboxamide compounds",
    "patent_number": "US12759999",
    "uspto_assignee": "Bristol-Myers Squibb Company",
    "patent_abstract": "Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR 4 or N; R 1 , R 2 , R 3 , R 4 , and A are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.",
    "precision_class": "structural",
    "invention_explanation": "A family of indole-based chemical compounds designed to block Bruton's tyrosine kinase, a protein involved in immune-cell signaling.",
    "technologies_mentioned": [
      "medicinal chemistry",
      "BTK inhibitors",
      "pharmaceutical compositions"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/15cdaaef-6290-59cf-98ee-319b3de00fd4 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bms.com","limit":20}'